In:
Digestive Endoscopy, Wiley, Vol. 30, No. 4 ( 2018-07), p. 485-492
Abstract:
Endoscopic snare papillectomy ( ESP ) is an effective treatment for ampullary adenoma. Argon plasma coagulation ( APC ) is widely used as an additional method to control bleeding or ablate the residual tumor. However, the efficacy of this procedure has not yet been fully evaluated. This study aimed to evaluate the usefulness of APC as an additional method to ESP . Methods Patients who underwent ESP for ampullary adenoma between September 2005 and September 2015 were retrospectively reviewed. Using propensity score matching, we compared short‐ and long‐term outcomes between the ESP ‐with‐additional‐ APC group ( ESP + APC group) and the ESP ‐only group. Primary outcome was early post‐ ESP adverse events ( AE ), and secondary outcomes were late AE and recurrence. Results Among 109 patients, additional APC was carried out in 59 (54.1%) patients. After matching, 41 patients were included in both groups, respectively. Bleeding rate was significantly lower in the ESP + APC group than in the ESP ‐only group (7.3% vs 31.7%, odds ratio = 0.180, P 〈 0.01). However, there were no significant differences in other procedure‐related early AE such as pancreatitis (12.2% vs 19.5%, P = 0.365), cholangitis (2.4% vs 9.8%, P = 0.198), and perforation (2.4% vs 2.4%, P = 1.000) between the ESP + APC group and the ESP ‐only group. During the follow‐up period (mean 904 ± 868 days), papillary stricture (9.8% vs 4.9%, P = 0.405) and recurrence rates (24.4% vs 24.4%, P = 0.797) were not significantly different between the ESP + APC group and the ESP ‐only group. Conclusion Additional APC during ESP may have a beneficial effect by decreasing bleeding rate without harmful effects.
Type of Medium:
Online Resource
ISSN:
0915-5635
,
1443-1661
DOI:
10.1111/den.2018.30.issue-4
Language:
English
Publisher:
Wiley
Publication Date:
2018
detail.hit.zdb_id:
2020071-7
Permalink